Evidence map›Paper›PMID 40384558›Full record

ReviewProtein science : a publication of the Protein Society2025

Experimental methods for studying amyloid cross-interactions.

Aleksandra Kalitnik, Anna Lassota, Oliwia Polańska, Marlena Gąsior-Głogowska, Monika Szefczyk, Agnieszka Barbach, Jarosław Chilimoniuk, Izabela Jęśkowiak-Kossakowska, Alicja W Wojciechowska, Jakub W Wojciechowski and 3 more

Abstract readReview
In one paragraph

Review in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Experimental methods for studying amyloid cross-interactions.Protein science : a publication of the Protein Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aleksandra KalitnikDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0001-6241-6990
Anna LassotaSchool of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0001-6073-8603
Oliwia PolańskaDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0003-2263-8219
Marlena Gąsior-GłogowskaDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0002-7835-7523
Monika SzefczykDepartment of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0003-4779-6395
Agnieszka BarbachDepartment of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.ORCID 0000-0002-3499-8126
Jarosław ChilimoniukClinical Research Centre, Medical University of Białystok, Białystok, Poland.ORCID 0000-0001-5467-018X
Izabela Jęśkowiak-KossakowskaDepartment of Pharmacology, Faculty of Medicine, Wroclaw Medical University, Wrocław, Poland.ORCID 0000-0002-8829-4482
Alicja W WojciechowskaDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0002-9053-8212
Jakub W WojciechowskiDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0001-5289-653X
Natalia SzulcDepartment of Physics and Biophysics, Wrocław University of Environmental and Life Sciences, Wrocław, Poland.ORCID 0000-0003-2951-1827
Małgorzata KotulskaDepartment of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wrocław, Poland.ORCID 0000-0002-2015-5339
Michał BurdukiewiczClinical Research Centre, Medical University of Białystok, Białystok, Poland.ORCID 0000-0001-8926-582X

Funding

Medical University of Białystok B.SUB.25.576Narodowe Centrum Nauki 2019/35/B/NZ2/03997Narodowe Centrum Nauki 2023/51/D/NZ7/02847
6 · The paper itself

Abstract

Interactions between amyloid proteins represent the cornerstone of various pathogenic pathways, including prion conversion and co-development of distinct kinds of systemic amyloidosis. Various experimental methodologies provide insights into the effects of such cross-interactions on amyloid self-assembly, which range from acceleration to complete inhibition. Here, we present a comprehensive review of experimental methods most commonly used to study amyloid cross-interactions both in vitro and in vivo, such as fluorescence-based techniques, high-resolution imaging, and spectroscopic methods. Although each method provides distinct information on amyloid interactions, we highlight that no method can fully capture the complexity of this process. In order to achieve an exhaustive portrayal, it is necessary to employ a hybrid strategy combining different experimental techniques. A core set of fluorescence methods (e.g., thioflavin T) and high-resolution imaging techniques (e.g., atomic force microscopy or Cryo-EM) are required to verify the lack of self-assembly or alterations in fibril morphology. At the same time, immuno-electron microscopy, mass spectrometry, or solid-state NMR can confirm the presence of heterotypic fibrils.

Indexed as

AmyloidAmyloidogenic ProteinsAnimalsCryoelectron MicroscopyHumansMicroscopy, Atomic ForceAmyloidAmyloidogenic Proteinscross‐interactionscross‐seedingfibril polymorphismhigh‐resolution microscopythioflavin T

Identifiers

PMID40384558
PMCPMC12086524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.